CoChat

Genome editing: the road of CRISPR/Cas9 from bench to clinic

Open access
Eid, Ayman, Mahfouz, Magdy M · 2016 · Experimental & Molecular Medicine
Cited by 108

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Molecular scissors engineered for site-specific modification of the genome hold great promise for effective functional analyses of genes, genomes and epigenomes and could improve our understanding of the molecular underpinnings of disease states and facilitate novel therapeutic applications. Several platforms for molecular scissors that enable targeted genome engineering have been developed, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and, most recently, clustered regularly interspaced palindromic repeats (CRISPR)/CRISPR-associated-9 (Cas9). The CRISPR/Cas9 system’s simplicity, facile engineering and amenability to multiplexing make it the system of choice for many applications. CRISPR/Cas9 has been used to generate disease models to study genetic diseases. Improvements are urgently needed for various aspects of the CRISPR/Cas9 system, including the system’s precision, delivery and control over the outcome of the repair process. Here, we discuss the current status of genome engineering and its implications for the future of biological research and gene therapy. Improved methods for breaking and editing the genome will revolutionize genomic and biological research. Genome editing techniques known as ‘molecular scissors’ enable a cell's genome to be cut at a specific location, allowing genes to be removed, added or mutated as desired. These techniques help researchers understand the molecular mechanisms underpinning multiple diseases, and could lead to novel gene therapies for conditions such as Alzheimer's disease and HIV. Magdy Mahfouz and Ayman Eid at King Abdullah University of Science and Technology in Saudi Arabia reviewed the current status of several genome editing techniques and concluded that the newest system, ‘clustered regularly interspaced palindromic repeats’ (CRISPR/Cas9), holds the greatest potential to transform the field. The researchers call for further improvements in CRISPR/Cas9 to ensure that precision, delivery and control are refined in order to limit side-effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2016.111

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

Metadata

Authors
Eid, A., & Mahfouz, M. M.
Venue
Experimental & Molecular Medicine
Published
2016-10-14
Volume
48
Issue
10
Pages
e265-e265
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2531490221
Cited by
108
References
36
FWCI
6.17
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.